Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate for prevention of glucocorticoid-induced osteoporosis in malignant lymphoma
2015-005688-18Phase 2Completed
- Sponsor
- Aalborg University Hospital
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of alendronate in glucocorticoid-induced osteoporosis (GIOP) (2 arms), sponsored by Aalborg University Hospital. Primary endpoint: Change in T-score (bone mineral density). Started Apr 2016; status: completed.
02
Drugs
alendronate
03
Conditions
glucocorticoid-induced osteoporosis (GIOP)
Beyond the preview
Go deeper on 2015-005688-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005688-18.